Aktienanalyse zu Quantum Cyber NV (QUCY)

$1.420

-0.048 (-3.40%)Zum Schluss

Loading chart…

High: 1.500
Open: 1.480
VWAP: 1.43
Vol: 602.72K
Mkt Cap: —
Low: 1.355
Amount: 858.87K
EV/EBITDA, TTM: -0.75

Quantum Cyber N.V., formerly known as Mainz Biomed N.V., is a Germany‑based technology company engaged in the development of solutions in the fields of quantum computing and cybersecurity. The Company focuses on safeguarding digital infrastructure against emerging quantum‑related risks through technologies such as post‑quantum cryptography and defence‑related systems. Its activities include the development of applications supporting secure data protection and communication, as well as the establishment of a platform for quantum‑focused security technologies.

quantum-cyber.ai

AI analysis of Quantum Cyber NV (QUCY)

buy

Mainz Biomed NV (QUCY) appears to be a good buy right now due to its recent strong performance, with a year-to-date change of +68.23% and a positive market reaction to significant orders worth $2.09 million. However, the main risk is the potential dilution from the CEO's $6 million investment, which could impact existing shareholders if he sells his shares.

Bewertungskennzahlen

The current forward P/E ratio for Quantum Cyber NV (QUCY) is 0.00, compared to its 5-year average forward P/E of .

Forward P/E

5Y Average P/E

Current P/E

0.00

Forward EV/EBITDA

Fair

5Y Average EV/EBITDA

-0.64

Current EV/EBITDA

-0.75

Überbewertet

-0.37

Unterbewertet

-0.92

Forward P/S

Fair

5Y Average P/S

19.85

Current P/S

27.01

Überbewertet

28.13

Unterbewertet

11.56

Event-Zeitleiste

2026-08-20 (ET)